The Characteristics of Oral Microbiota in Chronic Pancreatitis and Autoimmune Pancreatitis
NCT07015580 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 360
Last updated 2025-06-11
Summary
There are more than 700 different bacteria colonized in human oral cavity, which are collectively referred to as oral microbiota. Emerging evidence suggests that oral microbiota plays a series of important roles in human health, such as immune response, carcinogen metabolism and nutrient digestion. The changes of oral microbiota composition are closely related to the occurrence and development of pancreatic diseases. Previous studies have found that there are dense bacterial biofilms in the pancreatic duct of patients with calcified pancreatitis, including oral bacterial types. However, most studies only focused on the changes of gut microbiota in patients with chronic pancreatitis, and there were lack of research and description on the changes of oral microbiota in patients with chronic pancreatitis. In this study, we will extract and sequence bacterie's full-length 16S rRNA to describe the characteristics of oral microbiota in patients with chronic pancreatitis, confirming that there are changes in oral microbiota in patients with chronic pancreatitis, and compare the differences of oral microbiota in patients with chronic pancreatitis, pancreatic cancer and autoimmune pancreatitis.
Conditions
- Oral Microbiota
- Pancreatitis
- Pancreatic Cancer
Interventions
- OTHER
-
16S rRNA sequencing
Clinical data including medical history, clinical symptoms, imaging examination, laboratory examination will be collected. 3-5ml saliva sample of every patients will be collected for 16S rRNA sequencing of oral microbiota.
Sponsors & Collaborators
-
Ruijin Hospital
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2025-02-18
- Primary Completion
- 2026-02-28
- Completion
- 2026-02-28
Countries
- China
Study Locations
More Related Trials
-
Prediction of Acute Pancreatitis Outcome
NCT06653205 ·Status: NOT_YET_RECRUITING
-
A Cross-sectional Study on the Association of Peptidoglycan Fragments Derived From Gut Microbiota With Alcohol Liver Disease
NCT07284862 ·Status: COMPLETED
-
Evaluating the Role of Immune Responses in the Emergence of Protease Inhibitor Mutations
NCT01517529 ·Status: COMPLETED
-
A Study of the Intestinal Microbiome in Patients with Cirrhosis
NCT06808698 ·Status: NOT_YET_RECRUITING
-
Single Cell Landscape of HBV-related Acute-on-chronic Liver Failure Patients
NCT06865859 ·Status: RECRUITING
-
Immune Dysregulation in Hepatitis C Patients With or Without Arthritis
NCT01195987 ·Status: UNKNOWN
-
Relationship Between Gut Microbiota And Anemia In Patients With Chronic Renal Failure
NCT03220685 ·Status: COMPLETED
-
Changes in High Sensitive C Reactive Protien With Different Treatment Modalities in Acute Pancreatitis
NCT03740685 ·Status: UNKNOWN
-
Immun Status at Pancreatitis Patients
NCT03937323 ·Status: COMPLETED
-
Neutrophil/Lymphocyte Ratio in Acute Pancreatitis
NCT05859633 ·Status: UNKNOWN
-
A Study on Factors of Biochemical Response in Autoimmune Hepatitis
NCT06356506 ·Status: NOT_YET_RECRUITING
-
Study to Determine the Response to COVID-19 Vaccination and Prevalence of COVID-19 in Subjects With Chronic Liver Disease
NCT05669677 ·Status: COMPLETED
-
Progranulin and CTRP3 in Metabolic Syndrome
NCT01668888 ·Status: COMPLETED
-
Surveillance for Early Liver Injuries Caused by Zhuanggu Guanjie Pill
NCT03060252 ·Status: UNKNOWN
-
Intervention, Prognosis and Mechanism of Covid-19 Infection in Patients With Underlying Diseases
NCT05965843 ·Status: UNKNOWN
-
Analyse of Inflammatory Activity of Sjögren's Syndrome on 68Ga-FAPI PET-CT
NCT07062523 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
iMmune SignAtures and Clinical outComes in AP
NCT05878236 ·Status: RECRUITING
-
Albumin Modifications as Early Biomarkers of Chronic Liver Diseases
NCT06318949 ·Status: RECRUITING ·Phase: NA
-
Study of Clinical Features of Patients With Autoimmune Liver Disease Complicated With Covid-19 and the Immune Mechanism Affecting Prognosis
NCT06099626 ·Status: UNKNOWN
-
Assessment of the Different Etiological and Susceptibility Markers in Patients With Pancreatitis: Investigating IG4, Cytomegalovirus, Coxsackie- Virus, Genetic Polymorphism of Vitamin D Receptor Gene
NCT03830073 ·Status: UNKNOWN
-
Biomarkers for Intestinal Permeability
NCT04667208 ·Status: COMPLETED
-
Discovery and Validation of Proteogenomic Biomarker Panels in Liver Transplant Recipients
NCT01672164 ·Status: COMPLETED
-
Investigation of the Influence of the Human Microbiome on Giant Cell Arteritis
NCT06279065 ·Status: RECRUITING
-
Prevalence and Clinical Course of Chronic Hep B Infection in IBD and Rheumatologic Disease
NCT02128503 ·Status: TERMINATED ·Phase: NA
-
Prospective Clinical Study of the Role of the Immune Response, in Relation to Diet, in Patients Affected by Either Chronic Hepatitis C Virus (HCV) Infection or Non Alcoholic Fatty Liver Disease (NAFLD)
NCT02038387 ·Status: UNKNOWN ·Phase: NA